The latest closing stock price for Calliditas Therapeutics AB as of September 19, 2024 is 40.16.
An investor who bought $1,000 worth of Calliditas Therapeutics AB stock at the IPO in 2020 would have $1,049 today, roughly 1 times their original investment - a 19.64% compound annual growth rate over 4 years.
The all-time high Calliditas Therapeutics AB stock closing price was 41.55 on September 03, 2024.
The Calliditas Therapeutics AB 52-week high stock price is 42.10, which is 4.8% above the current share price.
The Calliditas Therapeutics AB 52-week low stock price is 15.25, which is 62% below the current share price.
The average Calliditas Therapeutics AB stock price for the last 52 weeks is 26.48.
An investor who bought $1,000 worth of Calliditas Therapeutics AB stock at the IPO in 2020 would have $1,049 today, roughly 1 times their original investment - a 19.64% compound annual growth rate over 4 years.
The all-time high Calliditas Therapeutics AB stock closing price was 41.55 on September 03, 2024.
The Calliditas Therapeutics AB 52-week high stock price is 42.10, which is 4.8% above the current share price.
The Calliditas Therapeutics AB 52-week low stock price is 15.25, which is 62% below the current share price.
The average Calliditas Therapeutics AB stock price for the last 52 weeks is 26.48.